FI893916A - Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor. - Google Patents

Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor. Download PDF

Info

Publication number
FI893916A
FI893916A FI893916A FI893916A FI893916A FI 893916 A FI893916 A FI 893916A FI 893916 A FI893916 A FI 893916A FI 893916 A FI893916 A FI 893916A FI 893916 A FI893916 A FI 893916A
Authority
FI
Finland
Prior art keywords
molecules
lfa
subenhet
leukocytadhesionsreceptor
alfa
Prior art date
Application number
FI893916A
Other languages
English (en)
Other versions
FI893916A0 (fi
Inventor
Timothy Alan Springer
Richard Larson
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of FI893916A0 publication Critical patent/FI893916A0/fi
Publication of FI893916A publication Critical patent/FI893916A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
FI893916A 1988-08-23 1989-08-21 Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor. FI893916A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23522788A 1988-08-23 1988-08-23
US32101789A 1989-03-09 1989-03-09

Publications (2)

Publication Number Publication Date
FI893916A0 FI893916A0 (fi) 1989-08-21
FI893916A true FI893916A (fi) 1990-02-24

Family

ID=26928699

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893916A FI893916A (fi) 1988-08-23 1989-08-21 Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor.

Country Status (14)

Country Link
EP (1) EP0362526B1 (fi)
JP (1) JPH02306999A (fi)
KR (1) KR900002796A (fi)
AT (1) ATE123810T1 (fi)
AU (1) AU634974B2 (fi)
DE (1) DE68923048T2 (fi)
DK (1) DK412589A (fi)
ES (1) ES2075016T3 (fi)
FI (1) FI893916A (fi)
GR (1) GR3017303T3 (fi)
HU (1) HUT53673A (fi)
IL (1) IL91369A (fi)
NO (1) NO893366L (fi)
PT (1) PT91503B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502879A (ja) * 1987-02-26 1989-10-05 ダナ　ファーバー　キャンサー　インスティテュート Ｌｆａ―１のクローニング
US5395929A (en) * 1987-12-15 1995-03-07 Dana Farber Cancer Institute Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
WO1990010652A1 (en) * 1989-03-09 1990-09-20 Dana Farber Cancer Institute Method of treating viral infections using lfa-1
JPH04505613A (ja) * 1989-03-09 1992-10-01 ダナ・ファーバー・キャンサー・インスティチュート 白血球付着レセプター
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5871733A (en) * 1990-07-20 1999-02-16 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5120830A (en) * 1990-10-25 1992-06-09 Washington University Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
EP0762886A4 (en) * 1994-04-19 1999-03-31 Univ Kansas ICAM-1 / LFA-1 SHORT CHAIN PEPTIDES AND METHODS FOR USE THEREOF
US6017734A (en) * 1995-07-07 2000-01-25 The Texas A & M University System Unique nucleotide and amino acid sequence and uses thereof
US6075004A (en) 1996-04-26 2000-06-13 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
CA2346742A1 (en) * 1998-07-06 2000-01-13 University Of Utah Research Foundation Hyaluronic acid mimics and methods related thereto
DE60324794D1 (de) * 2003-09-04 2009-01-02 Biomay Ag Hypoallergene Polypeptide basierend auf aus Fisch gewonnenem Parvalbumin
CN105820160B (zh) 2003-11-05 2019-02-12 萨可德生物科学公司 细胞粘着调节剂
DE602005018325D1 (de) 2004-02-19 2010-01-28 Genentech Inc Antikörper mit korrigierten cdr
JP5794721B2 (ja) 2005-05-17 2015-10-14 サーコード バイオサイエンス インコーポレイテッド 眼障害の治療のための組成物および方法
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
US8080562B2 (en) 2008-04-15 2011-12-20 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
WO2014018748A1 (en) 2012-07-25 2014-01-30 Sarcode Bioscience Inc. Lfa-1 inhibitor and polymorph thereof

Also Published As

Publication number Publication date
JPH02306999A (ja) 1990-12-20
IL91369A0 (en) 1990-04-29
EP0362526A2 (en) 1990-04-11
NO893366L (no) 1990-02-26
NO893366D0 (no) 1989-08-22
KR900002796A (ko) 1990-03-23
AU634974B2 (en) 1993-03-11
PT91503A (pt) 1990-03-08
PT91503B (pt) 1996-04-30
DK412589D0 (da) 1989-08-22
DE68923048T2 (de) 1995-11-16
AU4014589A (en) 1990-03-01
GR3017303T3 (en) 1995-12-31
EP0362526B1 (en) 1995-06-14
ES2075016T3 (es) 1995-10-01
DK412589A (da) 1990-02-24
HUT53673A (en) 1990-11-28
DE68923048D1 (de) 1995-07-20
FI893916A0 (fi) 1989-08-21
ATE123810T1 (de) 1995-06-15
EP0362526A3 (en) 1990-07-18
IL91369A (en) 1994-08-26

Similar Documents

Publication Publication Date Title
FI893916A (fi) Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor.
EP0364690A3 (en) The alpha-subunit of the mac-1 leukocyte adhesion receptor
IL86246A0 (en) Intercellular adhesion molecules and functional derivatives thereof,their production and antibodies against thereto
NZ232833A (en) Intercellular adhesion molecule-2 (icam-2) and functional derivatives thereof
ATE125708T1 (de) Interzellulare adhäsions-moleküle und deren bindungsliganden.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: DANA FARBER CANCER INSTITUTE